FENNEC PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount
FENNEC PHARMACEUTICALS INC. (FENC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount of -$450.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsOther · last filed 2016-03-28
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, tax credit, other, amount for fiscal 2015 was -$450.00K.
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, tax credit, other, amount for fiscal 2014 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount 12 month |
|---|---|
| 2015-12-31 | -$450.00K 10-K · filed 2016-03-28 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |